ArticleCancers2022

Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN).

Emelie Gezelius et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.